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Abstract 
Background: There have been many studies on psychiatric disorders, but very little is known about the biology of 
suicide with schizophrenia. In the present study, we are looking for a possible connection between altered lipid pro-
file and suicidal behavior in schizophrenic Tunisian patients.
Methods: Assay of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c), low-density lipoprotein 
cholesterol (LDL-c), and triglycerides (TG) has been done for 126 schizophrenic patients with and without suicide 
attempts and 131 healthy controls recruited in the University Hospital of Monastir.
Results: TC and LDL-c levels were significantly higher in schizophrenic patients compared to controls. TC was signifi-
cantly lower in schizophrenic patients with suicide attempt compared to those without suicide attempt. Depending 
to the sonority of suicide attempt, TC was significantly lower in patients with recent suicide attempt compared to 
those with lifetime suicide attempt and without suicide attempt (p < 0.001), and no significant differences between 
TG, LDL-c, and HDL-c were noted.
Conclusions: Results of this study showed that TC levels in schizophrenic patients after a recent suicide attempt 
are significantly lower than in patients without suicide attempt and with lifetime suicide attempts. TC can be one of 
biological markers defined suicidal risk for schizophrenic patients.
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Background
Suicide, a public health problem of high complexity with 
different etiological factors, is causing annually a prema-
ture loss of approximately one million lives worldwide [4] 
Suicide is the third most common cause of death in vari-
ous countries in the 15–44 years age group, and the sec-
ond most common cause of death in the 10–24 years age 
group (OMS [28]), and is still poorly understood. New 
approaches are therefore needed to complement the fun-
damental of social influences, cultural and individual pro-
pensity to suicide. Suicide is the chief cause of premature 
death among patients with schizophrenia [5]. The rate of 
suicide in schizophrenic patients is several times higher 
than in the general population. Identification of those at 
highest risk remains a problem for the clinician. Patients 
who have previously attempted suicide form a well-
defined, high-risk group for suicide. It has been shown in 
other studies [16, 17, 39] that the prevalence of lifetime 
suicide attempts in females is almost twice than of males 
(7 vs. 4%, respectively), although the difference did not 
reach significant level.
In particular, improved prevention strategies are 
required in addition to extensive scientific study. Many 
researchers have focused on the search of biologi-
cal markers that may be linked to suicidal behavior and 
can be used as an additional instrument for prevention 
and therapeutic action. It has been found that metabolic 
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deregulation, especially altered lipid profile including low 
total cholesterol (TC) and low-density lipoproteins-cho-
lesterol (LDL-c) levels, may underlie higher suicide risk 
in patients with schizophrenia [1, 3]. A number of stud-
ies have investigated a possible link between low serum 
cholesterol and psychiatric symptoms, especially suicidal 
behavior [36]. These findings might be explained by the 
hypothesis that reduced cholesterol level contributes to 
decreased serotonergic transmission due to altered affin-
ity and function of serotonin receptors and transporters 
[8]. It has been further hypothesized that low peripheral 
and central cholesterol levels may reduce lipid viscosity 
of neuronal cell membranes lowering the availability of 
pre-synaptic serotonin transporters and post-synaptic 
serotonin receptors [21, 38]. However, it should also be 
noted that some studies have failed to prove an associa-
tion between lipid profile and suicide in patients with 
schizophrenia [20, 22, 29, 34]. In sum, cholesterol has 
received attention as a potentially meaningful biomarker 
for suicide.
Most previous studies with clinical population had 
small samples, and focused on total cholesterol as the 
measure of interest. Given that each lipoprotein sub-
fraction has a different role in the human body, total 
cholesterol might not be sufficient to determine the rela-
tionship between lipids and suicidality. Additionally, it is 
not clear whether a lower lipid profile is either a state or 
trait marker for suicide. Other blood markers should be 
compared in the same population to investigate poten-
tial biomarkers equally and to evaluate group differences 
between suicide attempters and non-attempters.
Therefore, in the present study, we investigated the 
possible connection between serum cholesterol, triglyc-
erides, HDL-c and LDL-c levels, and suicide for schizo-




The protocol of this study was approved by the ethical 
committees of the University Hospital in Monastir. After 
providing consent, 126 subjects (91 men and 35 women) 
with the age range of 20–65 years were recruited during 
11 months (April 2013–March 2014) at the Department 
of psychiatry, in the University Hospital of Monastir, 
which is located in the Mid-eastern part of Tunisia. We 
recruited patients randomly but only those that met the 
inclusion criteria for our study. Socio-demographic and 
clinical data were collected by an information sheet and 
from the medical record of the patient. We excluded all 
patients with metabolic disorders. The blood sample 
of the control group was taken from the blood bank of 
University Hospital in Monastir Tunisia; 131 Healthy 
controls (94 men and 37 women) did not have any mental 
or metabolic illness and they are in the same age range 
of patients (20–65  years). The suicide attempts were 
divided into two groups: lifetime suicide group (who had 
attempted suicide for more than 2  months) and recent 
suicide group (who had attempted suicide for less than 
2 months). BMI was calculated as the weight (kilograms) 
divided by the square of the height (square meters).
Assessment
Venipuncture was performed for all subjects between 
8 and 9 a.m. after a 12  h overnight fast. Approximately 
5  ml of blood was collected. Immediately after col-
lecting blood samples, serum concentration of total 
cholesterol (TC), high-density lipoprotein cholesterol 
(HDL-c), and triglycerides (TG) were determined using 
enzyme methods on COBAS 6000™ automates ana-
lyzer, and low-density lipoprotein cholesterol (LDL-c) 
was calculated with the Friedewald equation. Reference 
intervals for the measured parameters were as follows: 
TC <5.0 mmol/L, LDL <3.0 mmol/L, HDL >1.0 mmol/L, 
and TG <1.7 mmol/L.
Measurements
Table 1 shows comparison of socio-demographic details 
(age, gender, BMI, smoking status, and alcoholic status) 
between patients and controls.
The structured clinical interview for diagnostic and 
statistical manual of mental disorder-IV (DSM-IV) for 
schizophrenia was applied to assess the psychiatric status 
of individuals.
In the current study, we have two groups: schizo-
phrenic patients and healthy controls. Schizophrenic 
patients are divided into schizophrenic patients without 
suicide attempts, schizophrenic patients with lifetime 
suicide attempts, and schizophrenic patients with recent 
suicide attempts.
Psychometric scales
For all patients, we conducted a psychometric assess-
ment through psychometric scales: PANSS (Positive and 
Negative Syndrome Scale) which enables the assessment 
of positive symptoms, negative, and general psychopa-
thology, CGI (Clinical Global Impression) which allows 
assessment of the severity, the therapeutic index, and 
improvise patients under treatment, EGF (Global Assess-
ment of Function), BPRS (Brief Psychiatric Rating Scale), 
and CALGAGY (Depression Scale For Schizophrenia).
Data analysis methods
Data collected from medical, laboratory, and treatment 
records were noted and entered into a database: SPSS for 
the Windows 20.0 package program was used for analyses 
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to compare the clinical and demographic characteristics 
variables between patients and healthy subjects.
All data are presented as the mean ±  standard devia-
tion (SD) or as n (%). Analysis of various, Chi square test, 
independent simple t test, was used for the comparisons 
whenever appropriate. A result of p < 0.05 was accepted 
as significant.
Results and discussion
A total of 126 subjects with schizophrenic disorders were 
included in this study; 55 subjects had presented an epi-
sode of suicide attempt (15 had a recent suicide attempt-
ers and 40 had a lifetime suicide attempters) and 71 
patients without any suicidal behavior. In this study, we 
have more males than females (Table 1).
BMI was significantly higher in schizophrenic patients 
compared to controls. The majorities of our patients 
smoke and do not consume alcohol.
Suicidal thoughts were reported by 37.4% of men and 
60% of women with schizophrenia. The predominant 
type of schizophrenia was undifferentiated for patients 
without suicide attempt (47.88%) and paranoid for 
patients with suicide attempt (45.44%).The majority of 
the prescribed Antipsychotic Drugs are typical (83.1%). 
In this study, we found that differences in psychometric 
scores between patients with and without suicide attempt 
are significantly higher in schizophrenic patients with 
suicide attempts for PANSS (general, positive, and nega-
tive), CGI Severity and BPRS are significantly higher in 
schizophrenic patients with suicide attempts (Table 2).
Concentrations of total cholesterol and LDL-c were 
significantly higher in schizophrenic patients compared 
with controls. No relationship with HDL-c and triglycer-
ides was found (Fig. 1).
Each lipid measure of the schizophrenic patients with 
recent suicide attempt, with lifetime suicide attempts, 
and without suicide attempt is shown in Table  3. The 
level of TC in the schizophrenic group with recent sui-
cide attempts was significantly lower than schizophrenic 
groups with lifetime suicide attempts and without suicide 
attempts. There were no statistically significant differ-
ences in the LDL-c, HDL-c, and TG levels between these 
groups.
The comparison reveals no differences in concentra-
tions of TC, TG, HDL-c, and LDL-c between patients 
treated with typical, atypical, and association between 
these two classes of Neuroleptics drug (Table 4).
Significant correlations between TC levels and EGF 
score as well as between the differences in TC levels 
and CALGARY score were found only for the sub-
group of recent suicide attempters, indicating that 
TC levels may serve as a predictive factor for suicide 
attempts in patients with schizophrenia. There were 
also no associations between TC levels and score in 
PANSS (general, positive, and negative), CGI (sever-
ity, over all improvement, and therapeutic index), and 
BPRS (Table 5).
According to the threshold values represented by the 
Roc curve (Figs. 2 and 3), we divided our study of popula-
tion to compare the effective of each interval. The results 
are summarized in Table 6. 
In suicidal risk for patients with schizophrenia, the cut-
off value of 3.76 mmol/L of TC was optimum, and at that 
point, sensitivity was 69% and specificity 31%. The area 




Schizophrenia group (n = 126) Controls group (n = 131)
Gender
 Male 91 (72.2%) 94 (71.8%) 0.934
 Female 35 (27.8%) 37 (28.2%)
Sex ratio 2.6 2.54
Age (year) 43.44 ± 10.60 40.81 ± 14.60 0.101
BMI (kg/m2) 26.25 ± 5.86 24.86 ± 3.82 0.026
Smoking status
 Smoking 73 (57.9%) 54 (41.2%) 0.713
 No-smoking 51 (40.5%) 77 (58.8%)
 Weaned 2 (1.6%) 0 (0%)
Alcoholic status
 Consumer 24 (19%) 14 (10.7%) 0.056
 No-consumer 102 (81%) 117 (89.3%)
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under the curve was statistically significantly lower in 
patients with a recent suicide attempt than for patients 
without suicide attempt (p < 0.001).
Schizophrenia is a serious mental disorder, and previ-
ous literature has reported that suicide was one of the 
main causes of premature death for sufferers from schizo-
phrenia which was the major risk factor for complete sui-
cide [32]. Cholesterol is a core component of the central 
nervous system (CNS), essential for the cell membrane 
stability, and the correct functioning of neurotransmis-
sion [33]. In our study, we found that TC was significantly 
higher among patients with schizophrenia compared to 
controls. Other studies have also shown that TC is higher 
among patients with schizophrenia compared to controls 
[25].
Considering the type of schizophrenia and according to 
our results and considering the type of schizophrenia, the 
majority of our patients with a suicide attempts are para-
noid-type (41.81%), while the majority of patients with-
out a suicide attempts are undifferentiated (46,47%), but 
the difference between the two types was not significant. 
The same results were found by Huang et al. [22].
Table 2 Clinical characteristics of schizophrenic patients with and without suicide attempts
Patients without SA (n = 71) Patients with SA (n = 55) p
Psychometric evaluation
 PANSS general 35.25 ± 14.97 41.71 ± 15.86 0.021
 PANSS positive 14.70 ± 6.83 19.80 ± 8.88 <0.001
 PANSS negative 17.52 ± 8.93 20.76 ± 9.02 0.046
 CGI severity 3.01 ± 1.61 3.31 ± 1.46 <0.001
 CGI overall improvement 2.32 ± 1.20 2.22 ± 0.91 0.292
 CGI therapeutic index 4.94 ± 3.49 5.20 ± 3.34 0.590
 EGF 61.42 ± 18.21 53.27 ± 17.44 0.678
 BPRS 53.49 ± 23.53 69.24 ± 25.24 0.012
 Calgary 6.56 ± 10.11 8.31 ± 6.21 0.262
Type of schizophrenia
 Undifferentiated 35 (47.88%) 17 (30.90%) 0.113
 Paranoid 23 (32.39%) 25 (45.44%)
 Disorganized 13 (18.30%) 13 (23.64%)
Neuroleptics
 Typical 59 (83.1%) 47 (85.5%) 0.952
 Typical and atypical 12 (16.9%) 8 (13.5%)
 Doses of chlorpromazine 990.07 ± 617.703 963.18 ± 652.663 0.814
 Age at onset (year) 25.99 ± 8.39 25.26 ± 8.98 0.643
Fig. 1 Plasma concentrations of lipid parameters in schizophrenic 
patients and controls. *ANOVA: p adjusted for BMI
Table 3 Comparison of lipid profile in schizophrenic patients depending on the seniority of suicide attempt
Blood levels Recent suicide  
attempters
Group 1 (n = 15)












TC (mmol/L) 3.19 ± 1.00 4.02 ± 0.96 4.39 ± 0.98 0.000 0.007 0.000 0.063
HDL-C (mmol/L) 1.66 ± 0.94 1.64 ± 1.04 1.64 ± 0.93 0.995 0.935 0.920 0.994
LDL-C (mmol/L) 1.04 ± 0.36 1.04 ± 0.27 1.04 ± 0.27 0.921 0.947 0.848 0.691
TG (mmol/L) 2.60 ± 0.50 2.62 ± 1.11 2.62 ± 1.12 0.847 0.934 0.746 0.597
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The gender difference regarding risk of suicide attempt 
is well known. The well-known risk of attempted suicide 
is higher in females [31]. Accordingly, our study included 
more males than females with a suicide attempt. Higher 
frequency of alcohol consumption is found for patients 
(19%) compared to healthy controls (10.7%). In this 
study, alcohol consumption is less frequent compared to 
the results of North America or European studies which 
found high rates of use alcohol (rang 21–51%) [12]. These 
differences may be linked to availability of alcohol or 
cultural factors, in particular to the social pressure for 
alcohol abstinence in Tunisia as in other Islamic coun-
tries (Table 7).
Therefore, the results obtained here corroborate most 
studies in which a relationship between suicidal behav-
ior and low TC in schizophrenia patients was observed 
[26, 27]. Other studies did not find associations between 
serum cholesterol and death by suicide in patients with 
schizophrenia [35]. Some studies about attempted sui-
cide mainly focused on patients suffering from major 
depression. Almeida-Montes et  al. [2] found no signifi-
cant difference in lipid profiles between patients who had 
attempted suicide and those who had not among patients 
with a diagnosis of a major depressive episode. No asso-
ciation between TC levels and suicidal act was shown in 
bipolar patients and those with major depressive disorder 
[8]. The same study showed that TG is significantly lower 
in those patients. The question has thus arisen as to why 
cholesterol levels have been found to be correlated with 
suicide attempts in some studies and not in others. Race 
differences in serum lipid profiles and lipoprotein lipase 
activity may be a culprit [15]; nutritional habits, life style, 
traditions, as well as seasons and climate may play a role 
in explaining these differences [10, 18, 19].
On the other hand, no association with Triglycerides, 
LDL cholesterol, and HDL cholesterol was observed in 
these patients for any lipidic parameter, which was also 
the case in the present study. However, Janusz et al. [23] 
have reported that total cholesterol, LDL cholesterol, 
total lipids, and triglycerides are significantly lower in 
patients with schizophrenia who had a suicidal attempt. 
In terms of gender differences, we must emphasize that 
females may be especially sensitive to dieting-induced 
changes in the central serotonin function [39].
Lower lipid levels in people with schizophrenia may 
also relate to the occurrence of metabolic syndrome. In 
relation to this, Vuksan-Cusa et  al. [37] observed that 
the prevalence of metabolic syndrome in people with 
schizophrenia was lower in suicide attempters than in 
non-attempters. A post-mortem study reported down 
regulation of lipid metabolism mortem genes in the fron-
tal cortex of suicide completers [24].
The aims of our study was to calculate the new cutoff 
value of total cholesterol according to the location of 
suicide in schizophrenic patients using Roc curve which 
was described by plotting the sensitivity on the y-axis 
against 1-specificity on the x-axis for each of several cut-
offs. The results are interesting for total cholesterol in 
which 80% of patients with recent suicide attempt have 
a rate of TC ≤3.76 against 36.6% for patients without sui-
cide attempt. Among patients who have not attempted 
suicide, 36.6% had rate of total cholesterol ≤3.76. Lipid 
profile of these patients should be controlled regularly to 
prevent suicide risk among them.
Table 4 Variations of lipid profile in schizophrenic patients 
according to the treatment
Neuroleptics p
Typical [1] Atypical [3] Typical and atypi-
cal [4]
TC (mmol/L) 4.16 ± 1.07 4.05 ± 0.25 4.05 ± 1.01 0.933
TG (mmol/L) 1.70 ± 1.41 1.41 ± 0.87 1.26 ± 0.64 0.210
HDL-C (mmol/L) 1.03 ± 0.28 1.21 ± 0.36 1.17 ± 0.48 0.145
LDL-C (mmol/L) 2.57 ± 0.98 2.25 ± 0.50 2.56 ± 0.72 0.797
Table 5 Correlation of  lipid profile in  schizophrenic 
patients according to  the psychometric evaluation 
for patients with recent suicide attempt
TC (mmol/L) TG (mmol/L) HDL-c (mmol/L) LDL-c (mmol/L)
PANSS general
 r −0.050 −0.19 −1.17 0.04
 p 0.575 0.830 0.191 0.967
PANSS +
 r −0.11 −0.014 −0.093 0.076
 p 0.901 0.875 0.301 0.398
PANSS −
 r 0.073 0.018 −0.020 −0.006
 p 0.418 0.844 0.824 0.946
CGI severity
 r −0.036 0.029 −0.142 0.039
 p 0.689 0.749 0.114 0.664
CGI improving patients under treatment
 r −1.06 0.051 −0.075 −0.006
 p 0.237 0.569 0.404 0.945
CGI therapeutic index
 r −0.057 −0.075 −0.090 −0.06
 p 0.523 0.406 0.315 0.502
EGF
 r −0.186 −0.058 −0.0514 −0.119
 p 0.037 0.515 0.550 0.184
Calgary
 r 0.222 −0.046 0.132 0.150
 p 0.012 0.609 0.139 0.093
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Table 6 Total cholesterol, triglycerides, HDL-c, and  LDL-c levels in  schizophrenic patients with  and without  suicide 
attempters
Schizophrenia OR Confidence interval 95% p
Without SA N = 71 With SA N = 55
TC (mmol/L)
 ≤3.51 12 (16.9%) 21 (38.2%) 3.037 1.330–6.932 0.002
 >3.51 59 (83.1%) 34 (61.8%)
TG (mmol/L)
 ≤1.61 41 (57.7%) 34 (61.8%) 0.844 0.411–1.733 0.785
 >1.61 30 (42.3%) 21 (38.2%)
HDL-C (mmol/L)
 ≤1.10 39 (54.9%) 36 (65.5%) 0.643 0.311–1.330 0. 563
 >1.10 32 (45.1%) 19 (34.5%)
LDL-C (mmol/L)
 ≤2.5 39 (54.9%) 24 (43.6%) 1.574 0.775–3.198 0.480
 >2.5 32 (45.1%) 31 (56.4%)
AUC Sensibility Specificity Cut off value p
TC (mmol/L) 0.801 69% 31% 3.76 <0.001
HDL-C (mmol/L) 0.496 33.8% 66.2% 1.71 0.964
LDL-C (mmol/L) 0.598 38% 62% 1.13 0.641
TG (mmol/L) 0.449 45.1% 54.9% 2.5 0.539
Fig. 3 Roc curve assessing the different threshold values (TC, TG, HDL-c, and LDL-c) for patients with schizophrenia based on seniority of SA history
AUC Sensibility Specificity Cut off value p
CL (mmol/L) 0.658 56.3% 43.7% 3.76 0.002
HDL-C (mmol/L) 0.463 45.1% 54.9% 1.58 0. 563
LDL-C (mmol/L) 0.530 45.1% 54.9% 1.05 0.480
TG (mmol/L) 0.514 42.3% 57.7% 1.99 0.785 
Fig. 2 Roc curve assessing the different threshold values (TC, TG, HDL-c, and LDL-c) for patients with schizophrenia based on SA history
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However, a unique measure of TC level may not reflect 
patient’s basic state. We cannot conclude if lower cho-
lesterol is a state or a trait factor in suicide attempters. It 
is important to define an a priori biological threshold to 
distinguish subjects with low and high cholesterol. Addi-
tionally, since the study was conducted in a single univer-
sity hospital, the finding may not be representative of all 
Tunisian patients with schizophrenia.
The absence of difference for triglyceride levels sug-
gests that the association between cholesterol and sui-
cidal risk is not influenced by nutritional status.
The effect of medication on cholesterol level is a poten-
tial confounder not taken into account in this study. 
Moreover, psychotropic drugs are usually associated with 
high cholesterol levels.
The relationship between low serum cholesterol levels 
and suicidal behavior is far from clear. There have been 
numerous hypotheses that have attempted to explain the 
mechanisms by which cholesterol levels may influence 
the risk of attempting suicide. The most widely held view 
is that there may be a link between serum cholesterol lev-
els and the central nervous serotonergic system [7] via 
the reduction of brain serotonin activity [11]. Another 
hypothesis is that the phospholipids metabolism is dis-
rupted, combining a deficit of incorporation of polyun-
saturated fatty acids in the membrane with an increase 
their destruction [8]. Others have suggested that choles-
terol may affect disease state and behaviors, as it plays 
a role in the production of the myelin sheath, in trans-
membrane exchange, enzyme function, in the synthe-
sis of steroid hormones, and neurotransmitter receptor 
expression [14].
However, it should be stressed that an association 
between low cholesterol and suicidal behavior in schiz-
ophrenia was not confirmed in a number of studies [22, 
30]. Recently, Freemantle et al. [13] analyzed brain oxys-
terol levels, which are enzymatic oxidation products of 
cholesterol, in the prefrontal cortex of suicide victims. 
Their results show a significant increase in 24-hydrox-
ysterol, reflecting a higher turnover of cholesterol. They 
suggest that this metabolic process may be responsible 
for a reduction in central and peripheral cholesterol in 
these subjects. These authors also found altered phos-
pholipids levels connected with increased activity of 
cholesteryl ester hydrolase, which may impair inhibitory 
neurotransmission in the prefrontal cortex of subjects 
with violent suicides [13].
In subsequent studies, we will aim for the study of 
genes implicated in the transition to the suicidal act in 
patients with schizophrenia. We hypothesize that an 
array of alteration in genes responsible for lipid regula-
tion is incremented in the suicide for schizophrenic 
patients.
As most of the studies yielding negative results in this 
respect were performed in Asian populations, it can be 
speculated that ethnic differences may play a role.
Conclusion
The results show that total Cholesterol levels are low in 
suicide attempters after a recent suicide attempt, and 
remain lower than normal in a later time after the event.
Suicide prevention in patients with schizophrenia 
remains fundamental in the same way as the reduction of 
positive and negative symptoms, or improving the qual-
ity of life and reducing disability caused by the disease. 
We should automatically track a patient with schizophre-
nia suicidal risk factors or situations that promote their 
development.
One of the most important areas of research in suicide 
of schizophrenic patients should be based on the iden-
tification of biomarkers that may identify those patients 
prone to this risk of suicidal acts which is seemed 
important to focus on the specific involvement of fluid-
ity membrane, and it is desirable to complete the analy-
sis of lipid metabolism by assaying the various fractions 
of blood cholesterol to determine those included in this 
relationship.
Limitations
The limitations of our study are the following: First, the 
sample size in the recent suicide attempt subgroup was 
small. It would be interesting to increase the sample size 
for this subgroup. The data for the current study were 
obtained from the region of Monastir. Future studies on 
this research topic may be conducted in larger and more 
Table 7 Total cholesterol, triglycerides, HDL-c, and  LDL-c 
levels in schizophrenic patients with schizophrenia based 
on seniority of SA
Schizophrenia OR Confidence 
interval 95%
p
Lifetime SA Recent SA
TC (mmol/L)
 ≤3.76 26 (36.6%) 12 (80%) 6.923 1.787–26.816 <0.001
 >3.76 45 (63.4%) 3 (20%)
TG (mmol/L)
 ≤1.71 46 (64.8%) 9 (60%) 1.227 0.392–3.843 0.964
 >1.71 25 (35.2%) 6 (40%)
HDL-c (mmol/L)
 ≤1.13 44 (62%) 11 (73.3%) 0.593 0.171–2.049 0.641
 >1.13 27 (38%) 4 (26.7%)
LDL-c (mmol/L)
 ≤2.50 39 (54.9%) 6 (40%) 1.828 0.588–5.681 0.539
 >2.50 32 (45.1%) 9 (60%)
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diverse samples. Some variables, such as lipid total, were 
not measured in the present study, and this issue would 
be considered in the future investigation.
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HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein 
cholesterol; TC: total cholesterol; TG: triglycerides; SA: suicide attempt.
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